- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Showing 1–12 of 78 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
2027.04 |
376,00 € |
||
VEGF-A |
Monoclonal Antibody |
Zirabev® |
25 mg/mL |
– |
2 mg |
tba |
tba |
200,00 € |
||
VEGF-A |
Monoclonal Antibody |
Oyavas® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Alymsys® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Aybintio® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Abevmy® |
25 mg/mL |
– |
2 mg |
tba |
tba |
207,00 € |
||
VEGF-A |
Monoclonal Antibody |
Vegzelma® |
25 mg/mL |
– |
2 mg |
tba |
tba |
198,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.06 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.12 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.03 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.10 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
2021.03 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
2017.09 |
267,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
2018.03 |
267,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
2024.07 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2027.03 |
222,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
2027.09 |
997,00 € |
||
PD-1 |
Monoclonal Antibody |
Libtayo® |
50 mg/mL |
– |
5 mg |
tba |
tba |
569,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2019.11 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2020.01 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2021.05 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
2021.09 |
329,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2021.11 |
197,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
2024.08 |
1.161,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
2025.03 |
1.161,00 € |
||
CD20 |
Monoclonal Antibody |
Zevalin® |
1.6 mg/mL |
– |
0.1 mg |
tba |
tba |
2.317,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany